Titre : Régions déterminant la complémentarité

Régions déterminant la complémentarité : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Interpretation, Statistical
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régions déterminant la complémentarité : Questions médicales les plus fréquentes", "headline": "Régions déterminant la complémentarité : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régions déterminant la complémentarité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-06", "dateModified": "2025-03-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régions déterminant la complémentarité" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Région variable d'immunoglobuline", "url": "https://questionsmedicales.fr/mesh/D007135", "about": { "@type": "MedicalCondition", "name": "Région variable d'immunoglobuline", "code": { "@type": "MedicalCode", "code": "D007135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02.111.570.060.425" } } }, "about": { "@type": "MedicalCondition", "name": "Régions déterminant la complémentarité", "alternateName": "Complementarity Determining Regions", "code": { "@type": "MedicalCode", "code": "D022801", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Boris I Chobrutskiy", "url": "https://questionsmedicales.fr/author/Boris%20I%20Chobrutskiy", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, Oregon, USA." } }, { "@type": "Person", "name": "George Blanck", "url": "https://questionsmedicales.fr/author/George%20Blanck", "affiliation": { "@type": "Organization", "name": "Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA." } }, { "@type": "Person", "name": "Elena S Klimtchuk", "url": "https://questionsmedicales.fr/author/Elena%20S%20Klimtchuk", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Daniele Peterle", "url": "https://questionsmedicales.fr/author/Daniele%20Peterle", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Lawreen H Connors", "url": "https://questionsmedicales.fr/author/Lawreen%20H%20Connors", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Online Case-Based Course in Veterinary Radiographic Interpretation Generates Better Short- and Long-Term Learning Outcomes than a Virtual Lecture-Based Course.", "datePublished": "2022-11-29", "url": "https://questionsmedicales.fr/article/36542792", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3138/jvme-2022-0093" } }, { "@type": "ScholarlyArticle", "name": "Classification of SARS-CoV-2 sequences as recombinants via a pre-trained CNN and identification of a mathematical signature relative to recombinant feature at Spike, via interpretability.", "datePublished": "2024-08-26", "url": "https://questionsmedicales.fr/article/39186542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0309391" } }, { "@type": "ScholarlyArticle", "name": "Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature.", "datePublished": "2024-07-29", "url": "https://questionsmedicales.fr/article/39075659", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/his.15287" } }, { "@type": "ScholarlyArticle", "name": "How do people living with obesity who use obesity services perceive healthcare professionals' representation of the disease on social media? An interpretative phenomenological analysis.", "datePublished": "2024-04-15", "url": "https://questionsmedicales.fr/article/38626981", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-081066" } }, { "@type": "ScholarlyArticle", "name": "\"I don't know whether I will be alive or not\" - An interpretative phenomenological analysis of young adult males with Duchenne Muscular Dystrophy making sense of self and life.", "datePublished": "2023-12-30", "url": "https://questionsmedicales.fr/article/38182495", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.dhjo.2023.101578" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes biochimiques", "item": "https://questionsmedicales.fr/mesh/D001669" }, { "@type": "ListItem", "position": 4, "name": "Région variable d'immunoglobuline", "item": "https://questionsmedicales.fr/mesh/D007135" }, { "@type": "ListItem", "position": 5, "name": "Régions déterminant la complémentarité", "item": "https://questionsmedicales.fr/mesh/D022801" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régions déterminant la complémentarité - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régions déterminant la complémentarité", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régions déterminant la complémentarité", "description": "Comment identifier les CDR dans un anticorps ?\nQuels tests révèlent la présence de CDR ?\nLes CDR peuvent-ils être visualisés ?\nQuel rôle joue la bioinformatique dans l'étude des CDR ?\nLes CDR sont-ils spécifiques à chaque anticorps ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régions déterminant la complémentarité", "description": "Quels symptômes indiquent une réponse immunitaire anormale ?\nLes CDR affectent-ils les symptômes d'infections ?\nComment les CDR influencent-ils les maladies allergiques ?\nLes CDR sont-ils liés à des symptômes de maladies auto-immunes ?\nPeut-on prédire des symptômes grâce aux CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régions déterminant la complémentarité", "description": "Comment prévenir les maladies liées aux CDR ?\nLes CDR peuvent-ils être ciblés pour la prévention ?\nQuel rôle joue l'alimentation dans la prévention des maladies liées aux CDR ?\nLes tests génétiques aident-ils à prévenir les maladies liées aux CDR ?\nComment le mode de vie influence-t-il la prévention des maladies ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régions déterminant la complémentarité", "description": "Comment les CDR sont-ils utilisés en thérapie ?\nLes traitements ciblant les CDR sont-ils efficaces ?\nQuels types de médicaments ciblent les CDR ?\nLes CDR peuvent-ils être modifiés pour améliorer les traitements ?\nQuels sont les effets secondaires des traitements ciblant les CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régions déterminant la complémentarité", "description": "Quelles complications peuvent survenir avec des CDR défectueux ?\nLes CDR sont-ils impliqués dans des complications infectieuses ?\nComment les CDR affectent-ils les traitements anticancéreux ?\nLes complications liées aux CDR peuvent-elles être traitées ?\nQuels sont les risques de complications lors de thérapies ciblant les CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régions déterminant la complémentarité", "description": "Quels facteurs augmentent le risque de maladies liées aux CDR ?\nL'âge influence-t-il le risque lié aux CDR ?\nLe stress a-t-il un impact sur les CDR ?\nLes infections antérieures influencent-elles les CDR ?\nComment le mode de vie affecte-t-il les CDR ?", "url": "https://questionsmedicales.fr/mesh/D022801?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les CDR dans un anticorps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les CDR sont identifiés par séquençage et analyse des structures d'anticorps." } }, { "@type": "Question", "name": "Quels tests révèlent la présence de CDR ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'affinité et de liaison aux antigènes sont utilisés pour détecter les CDR." } }, { "@type": "Question", "name": "Les CDR peuvent-ils être visualisés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des techniques comme la cristallographie aux rayons X ou la RMN." } }, { "@type": "Question", "name": "Quel rôle joue la bioinformatique dans l'étude des CDR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La bioinformatique aide à prédire et modéliser les CDR à partir de séquences d'anticorps." } }, { "@type": "Question", "name": "Les CDR sont-ils spécifiques à chaque anticorps ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque anticorps a des CDR uniques qui déterminent sa spécificité." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réponse immunitaire anormale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des allergies ou des maladies auto-immunes peuvent survenir." } }, { "@type": "Question", "name": "Les CDR affectent-ils les symptômes d'infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des CDR efficaces peuvent réduire la gravité des symptômes d'infections." } }, { "@type": "Question", "name": "Comment les CDR influencent-ils les maladies allergiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des CDR spécifiques peuvent reconnaître des allergènes, entraînant des réactions." } }, { "@type": "Question", "name": "Les CDR sont-ils liés à des symptômes de maladies auto-immunes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des CDR mal régulés peuvent cibler des tissus sains, provoquant des symptômes." } }, { "@type": "Question", "name": "Peut-on prédire des symptômes grâce aux CDR ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des études sur les CDR peuvent aider à prédire la réponse immunitaire et les symptômes." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux CDR ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination et l'éducation sur les allergies peuvent aider à prévenir ces maladies." } }, { "@type": "Question", "name": "Les CDR peuvent-ils être ciblés pour la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des stratégies de vaccination ciblant les CDR peuvent prévenir certaines infections." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention des maladies liées aux CDR ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut renforcer le système immunitaire et prévenir les maladies." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils à prévenir les maladies liées aux CDR ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les risques et guider la prévention." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il la prévention des maladies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant exercice et gestion du stress, aide à prévenir les maladies." } }, { "@type": "Question", "name": "Comment les CDR sont-ils utilisés en thérapie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les CDR sont ciblés pour développer des anticorps thérapeutiques contre des maladies." } }, { "@type": "Question", "name": "Les traitements ciblant les CDR sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils montrent une efficacité dans le traitement de diverses maladies, y compris le cancer." } }, { "@type": "Question", "name": "Quels types de médicaments ciblent les CDR ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des anticorps monoclonaux et des inhibiteurs de points de contrôle immunitaire ciblent les CDR." } }, { "@type": "Question", "name": "Les CDR peuvent-ils être modifiés pour améliorer les traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la modification des CDR peut augmenter l'affinité et la spécificité des anticorps." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ciblant les CDR ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des réactions immunitaires indésirables et des allergies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des CDR défectueux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des CDR défectueux peuvent entraîner des maladies auto-immunes et des allergies." } }, { "@type": "Question", "name": "Les CDR sont-ils impliqués dans des complications infectieuses ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des CDR inefficaces peuvent aggraver les infections et retarder la guérison." } }, { "@type": "Question", "name": "Comment les CDR affectent-ils les traitements anticancéreux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des CDR mal ciblés peuvent réduire l'efficacité des traitements anticancéreux." } }, { "@type": "Question", "name": "Les complications liées aux CDR peuvent-elles être traitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements ciblés peuvent gérer les complications associées aux CDR." } }, { "@type": "Question", "name": "Quels sont les risques de complications lors de thérapies ciblant les CDR ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des réactions immunitaires indésirables et des effets secondaires graves." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de maladies liées aux CDR ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme la génétique, l'environnement et le mode de vie augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque lié aux CDR ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des CDR et augmenter le risque de maladies." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les CDR ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut altérer la réponse immunitaire et affecter les CDR." } }, { "@type": "Question", "name": "Les infections antérieures influencent-elles les CDR ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections passées peuvent modifier la structure et la fonction des CDR." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les CDR ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer la fonction des CDR et réduire le risque de maladies." } } ] } ] }

Sources (10000 au total)

Classification of SARS-CoV-2 sequences as recombinants via a pre-trained CNN and identification of a mathematical signature relative to recombinant feature at Spike, via interpretability.

The global impact of the SARS-CoV-2 pandemic has underscored the need for a deeper understanding of viral evolution to anticipate new viruses or variants. Genetic recombination is a fundamental mechan...

Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature.

Urothelial carcinoma (UC) demonstrates significant molecular and histologic heterogeneity. The WHO 2022 classification has hinted at adding molecular signatures to the morphologic diagnosis. As morpho... A survey instrument was shared among 98 uropathologists using SurveyMonkey software. Anonymized respondent data were analysed. The response rate was 85%. A majority were in concordance with the profil... In the era of precision medicine, enhanced understanding of molecular heterogeneity of UC will contribute to better therapeutic options, novel biomarker discovery, innovative management protocols, and...

How do people living with obesity who use obesity services perceive healthcare professionals' representation of the disease on social media? An interpretative phenomenological analysis.

The objective of this study was to explore how people living with obesity who use obesity services perceive healthcare professionals' (HCPs) online representation of the disease on social media. By ex... This was a qualitative study using a phenomenological framework. Following in-depth semi-structured interviews, analysis was undertaken to identify superordinate themes relating to how HCPs portray li... Patient advocacy organisation (The Irish Coalition for People Living with Obesity) and three clinical sites offering obesity treatment in Ireland.... 15 adult participants comprising of 12 women and 3 men who use social media and are living with obesity and who use obesity services.... Three key themes of how people living with obesity who use obesity services perceive HCP's online representation of the disease. (1) Negative experiences of HCPs-participants describe encountering wei... HCP's use of social media has a powerful impact on people with obesity who use healthcare and obesity services. Social media is a key tool in obesity awareness and education. We propose the '3E' frame...

"I don't know whether I will be alive or not" - An interpretative phenomenological analysis of young adult males with Duchenne Muscular Dystrophy making sense of self and life.

With ventilatory support, boys with Duchenne Muscular Dystrophy (DMD) now live longer. The emerging adulthood offers unanticipated opportunities for identity exploration. Existing literature has raise... Reveal lived experience and meaning making among men with advanced DMD living outside the western context.... Secondary data, essentially transcripts of semi-structured interviews with five young men with DMD, age ranging from 23 to 37 years, conducted as part of a larger study were analysed iteratively in de... Three themes encapsulated the essence of their lifeworld at this juncture. Each shared poignant stories of having survived adverse circumstances in the past, learning to live with themselves in the cu... Study findings expounded challenges men with advanced DMD grappled that ultimately shaped self-identity. Healthcare professionals could support this group of precarious survivors even better through i...

Non-invasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study.

Perineural invasion (PNI) of intrahepatic cholangiocarcinoma (ICC) is a strong independent risk factor for tumor recurrence and long-term patient survival. However, there is a lack of non-invasive too... This retrospective and prospective study included 243 patients with pathologically diagnosed ICC (training, n=136; external validation, n=81; prospective, n=26, respectively) who underwent preoperativ... Among 243 patients (mean age, 61.2 y ± 11.0 (SD); 152 men and 91 women), 108 (44.4%) were diagnosed as PNI-positive. The radiomics signature was constructed by seven radiomics features, with areas und... We developed and validated a robust combined model incorporating radiomics signature and clinicoradiological features based on machine learning to accurately identify the PNI statuses of ICC, and visu...

A deep learning-based interpretable decision tool for predicting high risk of chemotherapy-induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy.

This study aims to develop a risk prediction model for chemotherapy-induced nausea and vomiting (CINV) in cancer patients receiving highly emetogenic chemotherapy (HEC) and identify the variables that... Data from Tianjin Medical University General Hospital were collected and subjected to stepwise data preprocessing. Deep learning algorithms, including deep forest, and typical machine learning algorit... The deep forest model exhibited good discrimination, outperforming typical machine learning models, with an AUC of 0.850 (95%CI, 0.780-0.919), an F1 score of 0.757, an accuracy of 0.852, a specificity... The deep forest model demonstrated good discrimination in predicting the risk of CINV in cancer patients prescribed HEC. Kidney function, as represented by Ccr, played a crucial role in the model's pr...

'You learn to smile with your eyes', exploring the impact of enhanced personal protective equipment on primary care dental practitioners in the UK: An interpretative phenomenological study.

The aim of the study was to explore how dental practitioners in primary care settings perceive the impact of enhanced personal protective equipment (PPE) upon patient communication and wider clinical ... This study utilized a qualitative approach, rooted in critical realism. An interpretative phenomenological analysis (IPA) methodology was adopted as the study method. In accordance with IPA, in-depth ... Three themes were synthesized (related to communication and clinical practice): (1) Impaired communication and relationship building; (2) Physical impacts and required adjustments when wearing enhance... Dental Practitioners described several barriers to communication as well as physical and mental stressors caused by enhanced-PPE, all of which were perceived to impact upon the quality of care provide...

Access to HIV prevention, treatment, and care services during COVID-19 by men who have sex with men in Zimbabwe, An interpretive phenomenological analysis study.

Key populations are disproportionately affected by the human immunodeficiency virus (HIV) but have less access to HIV prevention and treatment services. The Coronavirus disease-2019 (COVID-19) pandemi... An interpretative phenomenological analysis design was applied to gain some insights regarding the lived experiences of MSM in accessing HIV prevention, treatment, and care services during COVID-19 lo... The findings demonstrated that during the COVID -19 lockdowns in Zimbabwe, MSM faced several barriers as they tried to access HIV services. Some of the barriers included the need for travel authorisat... Limited access to healthcare services by MSM due to COVID-19 lockdown may negatively affect the viral suppression and fuel the spread of HIV, which may reverse the gains toward the control of HIV epid...